Treatment Approaches for Pyelonephritis

Uncomplicated Pyelonephritis

The Infectious Diseases Society of America recommends using oral fluoroquinolones (ciprofloxacin 1000 mg extended-release for 7 days or levofloxacin 750 mg for 5 days) as first-line therapy for uncomplicated pyelonephritis in outpatients when local resistance is <10% 1
Fluoroquinolones are superior to all other oral agents for uncomplicated pyelonephritis, with 96-99% clinical cure rates 2
Use fluoroquinolones only when local E. coli resistance is ≤10% 1
Give one initial IV dose of ceftriaxone 1 g before starting oral fluoroquinolone therapy when fluoroquinolone resistance exceeds 10% 1
Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days can be used as an alternative oral agent if the organism is known to be susceptible, with clinical cure rates of 83% 2

Complicated pyelonephritis requires hospitalization with initial IV broad-spectrum antibiotics and longer treatment duration (10-14 days minimum) 1
Initial IV antibiotic regimens should be chosen based on local resistance patterns and severity, and may include fluoroquinolone IV, aminoglycoside ± ampicillin, extended-spectrum cephalosporin, or extended-spectrum penicillin ± aminoglycoside 3
Total duration of treatment for complicated infections should be 10-14 days minimum 3
Transition to oral therapy should occur after clinical improvement and based on susceptibility results 5
Blood cultures and imaging with CT scan are essential diagnostic workup for complicated cases 5

Always obtain urine culture before starting antibiotics 3
Tailor therapy based on susceptibility results 3
Expect clinical improvement within 48-72 hours; if not improving, reevaluate with imaging and repeat cultures 4